Exploring chemical probes to understand NEK kinases in cancer
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer
This study is looking at special proteins called NEK kinases that play a role in cancer, and it's for anyone interested in how we can better understand and treat cancer by developing new tools and treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10914164 on NIH RePORTER |
What this research studies
This research focuses on the NEK family of kinases, which are important proteins involved in regulating various biological processes related to cancer. The project aims to develop specific chemical probes and assays to study these kinases and their roles in cancer development and progression. By creating potent inhibitors and specialized cell lines, researchers hope to uncover how NEK kinases contribute to cancer and potentially identify new therapeutic targets. The findings will be shared with the scientific community to enhance understanding and treatment options for cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancers that may be linked to NEK kinases.
Not a fit: Patients with cancers unrelated to NEK kinases or those not seeking experimental treatment options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new cancer treatments by identifying and targeting specific kinases involved in tumor growth.
How similar studies have performed: Other research has shown promise in targeting kinases for cancer treatment, indicating that this approach could be a valuable addition to existing therapies.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Drewry, David Harold — Univ of North Carolina Chapel Hill
- Study coordinator: Drewry, David Harold
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.